Cardiovascular risk factors in obese women and their first-degree relatives

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 4, 2007, Pages 371-377

  Saraç, Fulden ^a,b   Özgen, Ahmet Gökhan ^a   Yilmaz, Candeǧer ^a   Tüzün, Mehmet ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cardiovascular risk; First degree relative; Obesity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCULATION; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOGEN BLOOD LEVEL; FREQUENCY ANALYSIS; HEART RATE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; RANK SUM TEST; RELATIVE; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FAMILY; FEMALE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HEART RATE; HUMANS; INSULIN; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TRIGLYCERIDES; TURKEY;

EID: 37349088104     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. WHO. World Health Organization. Obesity epidemic puts millions at risk from related diseases. Press Release WHO/48 (Online) June 12 1997. Available at http://www.who.int/inf-prp1997/en/pr97-46.html
2. James P, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Section 1: Obesity, the major health issue of the 21st century. Obes Res 2001; 9: 228-33.
3. Visscher T, Seidell J. The public health impact of obesity, Ann Rev Public 2001; 22: 355-75.
4. Kromhout D. Epidemiology of cardiovascular diseases in Europe. Public Health Nutr 2001; 4: 441-57.
5. Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976-80. Vital Health Stat 1987; 11: 1-73.
6. Chimonas ET. The treatment of coronary heart disease: An update. Part 2: Mortality trends and main causes of death in the Greek population. Curr Med Res Op 2001; 17: 27-33.
7. Mamalakis G, Kafatos A. Prevalence of obesity in Greece. Int J Obes Relat Metab Disord 1996; 20: 488-92.
8. Kafatos A, Diacatou A, Voukiklaris G, Nikolakakis N, Vlachonikolis J, Kounali D, et al. Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 years: the Seven Countries Study. Am J Clin Nutr 1997; 65: 1882-6.
9. James P. The dietary challenge for the European Union Public Health Nutr 2001; 4: 341-51.
10. Ahmad J, Ahmed F, Siddiqui MA, Hameed B, Ahmad I. Inflammation, insulin resistance and carotid IMT in first-degree relatives of north Indian type 2 diabetic subjects. Diabetes Res Clin Pract 2006; 73: 205-10.
11. Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, et al. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res 2004; 12: 1117-27.
12. Whitaker R, Wright J, Pepe M. Predicting obesity in young adulthood from childhood and parental obesity. EJM 1997; 337: 869-73.
13. Campbell P, Katzmarzyk P, Malina R, Rao D, Perusse L, Bouchard C. Stability of adiposity phenotypes from childhood and adolescence into young adulthood with contribution of parental measures. Obes Res 2001; 9: 394-400.
14. Krassas G, Tzotzas T, Tsametis C, Konstantinidis T. Prevalence and trends in overweight and obesity among children and adolescents in Thessaloniki, Greece. J Pediatr Endocrinol Metab 2001; 14: 1319-26.
15. WHO, World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, Switzerland; World Health Organization: 1998 Report WHO/NUT/98.1.
16. Dobbelsteyn C, Joffres M, MacLean D, Flowerdew G, and the Canadian Heart Health Surveys Research Group. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord 2001; 25: 652-61.
17. Ko G, Chan J, Cockram C, Woo J. Prediction of hypertension, diabetes, dyslipidemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23: 1136-42.
18. Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, St Victor R, et al. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol 2007; 14: 4.
19. Kaler SN, Ralph-Campbell K, Pohar S, King M, Laboucan CR, Toth EL. High rates of the metabolic syndrome in a First Nations Community in western Canada: prevalence and determinants in adults and children. Int J Circumpolar Health 2006; 65: 389-402.
20. Kolterman OG, Insel J, Saekow M, Olefsky M. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980; 65: 1272-84.
21. Akbartabartoori M, Lean ME, Hankey CR. Smoking combined with overweight or obesity markedly elevates cardiovascular risk factors. Eur J Card Preven 2006; 13: 938-46.
22. Mohn A, Marcovecchio M, Chiarelli F. Validity of HOMA-IR as index of insulin resistance in obesity. J Pediatr 2006; 148: 565-6.
23. Ferrannini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-57.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
25. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension 1995; 26: 290-3.
26. Ridker P, Hennekens C,. Buring J, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2002; 342: 836-43.
27. Pouliot M, Despres J, Lemieux S. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
28. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 187-8.
29. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 1998; 47: 1643-9.
30. Morisco C, Lembo G, Trimarco B. Insulin resistance and cardiovascular risk: new insights from molecular and cellular biology. Trends Cardiovasc Med 2006; 16: 183-8.
31. Ridker P, Rifai N, Koenig W, Blumenthal RS. C-reactive protein and cardiovascular risk in the Framingham Study. Arch Intern Med 2006; 26: 1327-8.
32. Balagopal P, Sweeten S, Mauras N. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab 2002; 282: 899-904.
33. Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethn Dis 2006; 16: 830-6.
34. Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006; 29: 2078-83.
35. Cuevas-Alvarez NA, Vela-Otero Y, Carrada-Brav T. Identification of risk factors in relatives of type-2 diabetics. Rev Med Inst Mex Seguro Soc 2006; 44: 313-20.
36. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-68.
37. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003; 167: 73-9.
38. Ryu SY, Lee YS, Park J, Kang MG, Kim KS. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci 2005; 20: 379-83.
39. Ridker PM. High-sensitive C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8.
40. Yudkin J.S, Stehouwer C.D, Emeis J, Coppack S. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-8.
41. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med 2000; 342: 836-43.
42. Kannel W, Neaton J, Wentworth D, Thomas H, Stamler J, Hulley S, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986; 112: 825-36.
43. Ridker P.M., Cushman M, Stampfer MJ, Tracy R. P, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-8.
44. Reaven G.M. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 1991; 121: 1283-8.
45. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91: 589-96.
46. Visser M, Bouter LM, McQuillan G.M, Wener M.H, Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 1992; 82: 2131-5.
47. Yan M, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2006; 295: 190-8.
48. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. In J Obes Relat Metab Disord 2002; 26: 1046-53.
49. Meyer HE, Sogaard AJ, Tverdal A, Selmer RM. Body mass index and mortality: the influence of physical activity and smoking. Med Sci Sports Exerc 2002; 34: 1065-70.